We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Long Non-coding RNAs in Cancer

    Long non-coding RNAs (lncRNAs) are emerging as cardinal biomarkers for diagnosis, prognosis, and therapy of cancers as well as precise therapeutic...
    Revathy Nadhan, Ciro Isidoro, ... Danny N. Dhanasekaran in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  2. Non-coding RNAs in disease: from mechanisms to therapeutics

    Non-coding RNAs (ncRNAs) are a heterogeneous group of transcripts that, by definition, are not translated into proteins. Since their discovery,...

    Kinga Nemeth, Recep Bayraktar, ... George A. Calin in Nature Reviews Genetics
    Article 15 November 2023
  3. Non-coding RNAs and Exosomal Non-coding RNAs in Traumatic Brain Injury: the Small Player with Big Actions

    Nowadays, there is an increasing concern regarding traumatic brain injury (TBI) worldwide since substantial morbidity is observed after it, and the...

    Omid Mohamadzadeh, Mahsasadat Ha**ouri, ... Hamed Mirzaei in Molecular Neurobiology
    Article 05 April 2023
  4. The Role of Non-coding RNAs in Cerebellar Development

    Since the sequencing of the human and various mammalian genomes, it is clear that there are far too few protein-coding genes to specify and...
    Maryam Rahimi-Balaei, Miguel Ramirez, ... Daniel Goldowitz in Development of the Cerebellum from Molecular Aspects to Diseases
    Chapter 2023
  5. Targeting and engineering long non-coding RNAs for cancer therapy

    RNA therapeutics (RNATx) aim to treat diseases, including cancer, by targeting or employing RNA molecules for therapeutic purposes. Amongst the most...

    Michela Coan, Simon Haefliger, ... Rory Johnson in Nature Reviews Genetics
    Article 29 February 2024
  6. Modulation of Long Non-coding RNAs in Cancer

    Cancer is associated to uncontrolled growth of cells. It is the second most common cause of death worldwide. Main treatment consists of surgery,...
    Glenda Nicioli da Silva, Lívia da Cunha Agostini, Tamires Cunha Almeida in Handbook of Cancer and Immunology
    Living reference work entry 2024
  7. Long Non-coding RNAs in Cancer

    Long non-coding RNAs (lncRNAs) are emerging as cardinal biomarkers for diagnosis, prognosis, and therapy of cancers as well as precise therapeutic...
    Revathy Nadhan, Ciro Isidoro, ... Danny N. Dhanasekaran in Handbook of Oncobiology: From Basic to Clinical Sciences
    Living reference work entry 2023
  8. Role of non-coding RNAs in neuroblastoma

    Neuroblastoma is known as the most prevalent extracranial malignancy in childhood with a neural crest origin. It has been widely accepted that...

    Ali Arash Anoushirvani, Arezoo Jafarian Yazdi, ... Hamed Mirzaei in Cancer Gene Therapy
    Article 22 May 2023
  9. G-quadruplexes from non-coding RNAs

    Non-coding RNAs (ncRNAs) are significant regulators of gene expression in a wide range of biological processes, such as transcription, RNA...

    Fangyuan Li, Jiang Zhou in Journal of Molecular Medicine
    Article 18 April 2023
  10. MicroRNAs and Long Non-coding RNAs as Key Targets

    Cancer is a potentially fatal and complex genetic disease characterized by the dysregulation of genome stability and cell proliferation, cell...
    Onur Obut, Pınar Akbaba, ... Vahap Eldem in Oncology: Genomics, Precision Medicine and Therapeutic Targets
    Chapter 2023
  11. Non-coding RNAs as skin disease biomarkers, molecular signatures, and therapeutic targets

    Non-coding RNAs (ncRNAs) are emerging as biomarkers, molecular signatures, and therapeutic tools and targets for diseases. In this review, we focus...

    Andrea Roso-Mares, Isabel Andújar, ... Bryan K. Sun in Human Genetics
    Article 14 August 2023
  12. MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV

    Human immunodeficiency virus (HIV) and human T cell leukemia virus (HTLV) have replicative and latent stages of infection. The status of the viruses...

    Sergio P. Alpuche-Lazcano, Robert J. Scarborough, Anne Gatignol in Retrovirology
    Article Open access 29 February 2024
  13. Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications

    Breast cancer is one of the most common malignancies that pose a serious threat to women's health. Reprogramming of energy metabolism is a major...

    Shiliang Xu, Lingxia Wang, ... Huan Yang in Journal of Biomedical Science
    Article Open access 26 February 2024
  14. Alterations of mRNAs and Non-coding RNAs Associated with Neuroinflammation in Alzheimer’s Disease

    Alzheimer’s disease is a neurodegenerative pathology whose pathognomonic hallmarks are increased generation of β-amyloid (Aβ) peptide, production of...

    Karla Aketzalli Hernández-Contreras, Jorge Antonio Martínez-Díaz, ... Gonzalo Emiliano Aranda-Abreu in Molecular Neurobiology
    Article 18 January 2024
  15. Non-coding RNAs and Aquaporin 4: Their Role in the Pathogenesis of Neurological Disorders

    Neurological disorders are a major group of non-communicable diseases affecting quality of life. Non-Coding RNAs (ncRNAs) have an important role in...

    Zahra Yaghoobi, Shahrzad Sadat Seyed Bagher Nazeri, ... Fatemeh Nabavizadeh in Neurochemical Research
    Article 19 December 2023
  16. The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer’s and Parkinson’s Diseases

    Clearance of accumulated protein aggregates is one of the functions of autophagy. Recently, a clearer understanding of non-coding RNAs (ncRNAs)...

    Abdolkarim Talebi Taheri, Zakieh Golshadi, ... Fatemeh Nabavizadeh in Cellular and Molecular Neurobiology
    Article Open access 10 March 2024
  17. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases

    Cardiovascular disease (CVD) is the leading cause of disease-related death worldwide and a significant obstacle to improving patients’ health and...

    **ang Ao, Wei Ding, ... Ying Liu in Journal of Molecular Medicine
    Article 04 April 2023
  18. Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions

    This review article presents an in-depth analysis of the current state of research on receptor tyrosine kinase regulatory non-coding RNAs (RTK-RNAs)...

    Aysan Moeinafshar, Mohammad Nouri, ... Mohammad-Reza Ghasemi in Cancer Cell International
    Article Open access 10 January 2024
  19. Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance

    Cancer is a complex disease with many contributing factors, and researchers have gained extensive knowledge that has helped them understand the...

    Chunjie Huang, Paniz Azizi, ... Poopak Farnia in Journal of Translational Medicine
    Article Open access 13 September 2023
  20. The Role of Non-coding RNAs in Drug Resistance of Cancers

    Cancer is a leading cause of mortality in patients worldwide. Some types of cancer treatment are surgery, chemotherapy, radiation therapy, targeted...
    Maedeh Arabpour, Nima Rezaei in Handbook of Cancer and Immunology
    Living reference work entry 2023
Did you find what you were looking for? Share feedback.